Richard Wunderink, MD, is a professor of Medicine in the Division of Pulmonary and Critical Care and a world-renowned expert in pneumonia. He shares his research and work on the Successful Clinical Response in Pneumonia Therapy (SCRIPT) project, including factors in the host that determine the susceptibility to develop pneumonia from viruses such as Coronavirus Disease 2019 (COVID-19), how it differs from other coronaviruses and how his work could translate into potential therapies.